Active ingredientEntacaponeCat. No. P-E058-001CAS 130929-57-6Family · Pharmaceutical analytical standards
Entacapone
An inhibitor of the COMT enzyme approved in Europe in 1998 and in the United States in 1999: in Parkinson's disease it is combined with levodopa, slowing its breakdown and prolonging its effect. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?A curious and completely harmless effect: in about one person in ten it turns urine orange, red or brown, because of the way the molecule is processed and eliminated.
Go to the active ingredient →Active ingredientEntacaponeCat. No. P-E058-001CAS 130929-57-6
Pharmacopoeial impurityEntacapone EP Impurity ACat. No. P-E058-002CAS 145195-63-7
Pharmacopoeial impurityEntacapone EP Impurity BCat. No. P-E058-003CAS 1215039-66-9
Pharmacopoeial impurityEntacapone EP Impurity CCat. No. P-E058-004CAS 116313-85-0
Pharmacopoeial impurityEntacapone EP Impurity DCat. No. P-E058-005CAS 857629-79-9
Pharmacopoeial impurityEntacapone EP Impurity ECat. No. P-E058-006CAS 7659-29-2
Pharmacopoeial impurityEntacapone EP Impurity FCat. No. P-E058-007CAS 160391-70-8
Pharmacopoeial impurityEntacapone EP Impurity GCat. No. P-E058-008CAS 1364322-41-7
Pharmacopoeial impurityEntacapone EP Impurity HCat. No. P-E058-009CAS 1150310-15-8
Pharmacopoeial impurityEntacapone EP Impurity ICat. No. P-E058-010CAS 1364322-42-8
MetaboliteEntacapone-3-beta-D-GlucuronideCat. No. P-E058-011
Isotopically labelledEntacapone-d10Cat. No. P-E058-012CAS 1185241-19-3
Impurity(E/Z)-3-O-Methyl EntacaponeCat. No. P-E058-013CAS 146698-91-1
Impurity2-Methoxy-4,6-dinitrophenolCat. No. P-E058-014CAS 4097-63-6
Impurity3-O-methylentacaponeCat. No. P-E058-015CAS 857629-78-8
ImpurityDenitroentacaponeCat. No. P-E058-016CAS 1217439-96-7
ImpurityEntacapone Amide ImpurityCat. No. P-E058-017CAS 158693-01-7
ImpurityEntacapone DimerCat. No. P-E058-018
ImpurityEntacapone Impurity 1Cat. No. P-E058-019
ImpurityEntacapone Impurity 2Cat. No. P-E058-020
ImpurityEntacapone Impurity 3Cat. No. P-E058-021CAS 158693-04-0
ImpurityEntacapone Impurity 4Cat. No. P-E058-022
ImpurityEntacapone Impurity 5Cat. No. P-E058-023
ImpurityEntacapone Impurity 6Cat. No. P-E058-024
ImpurityEntacapone Impurity 7Cat. No. P-E058-025
ImpurityEntacapone Impurity 8Cat. No. P-E058-026
ImpurityEntacapone Impurity 9Cat. No. P-E058-027CAS 158069-72-8
ImpurityEntacapone Impurity 10Cat. No. P-E058-028
ImpurityEntacapone Impurity 11Cat. No. P-E058-029CAS 1202160-40-4
ImpurityEntacapone Impurity 12Cat. No. P-E058-030
ImpurityEntacapone Impurity 13Cat. No. P-E058-031
ImpurityEntacapone Impurity 14Cat. No. P-E058-032
ImpurityEntacapone Impurity 15Cat. No. P-E058-033No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceEntacapone CRSEDQM code Y0001249Family EntacaponeImpurityEntacapone impurity A CRSEDQM code Y0001250Family EntacaponeNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.